G1 Therapeutics Appoints Mark Avagliano as Chief Business Officer

by NASDAQ Market News July 30, 2019

NASDAQ Market News
Click here to email author

RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%

Axsome Therapeutics To Report Second Quarter 2019 Financial Results On August 8, 2019

Ads